A detailed history of Manning & Napier Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Manning & Napier Group, LLC holds 229,630 shares of VRTX stock, worth $104 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
229,630
Previous 237,311 3.24%
Holding current value
$104 Million
Previous $96.6 Million 0.59%
% of portfolio
1.1%
Previous 1.15%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$407.69 - $446.08 $3.13 Million - $3.43 Million
-7,681 Reduced 3.24%
229,630 $96 Million
Q4 2023

Jan 19, 2024

SELL
$343.0 - $410.68 $4.05 Million - $4.85 Million
-11,817 Reduced 4.74%
237,311 $96.6 Million
Q3 2023

Oct 20, 2023

SELL
$338.18 - $362.46 $2.54 Million - $2.72 Million
-7,499 Reduced 2.92%
249,128 $86.6 Million
Q2 2023

Jul 26, 2023

SELL
$314.42 - $351.91 $2.4 Million - $2.68 Million
-7,625 Reduced 2.89%
256,627 $90.3 Million
Q1 2023

Apr 17, 2023

SELL
$283.23 - $323.1 $2.17 Million - $2.47 Million
-7,652 Reduced 2.81%
264,252 $83.3 Million
Q4 2022

Jan 26, 2023

SELL
$285.76 - $321.48 $1.43 Million - $1.6 Million
-4,987 Reduced 1.8%
271,904 $0
Q3 2022

Oct 18, 2022

SELL
$273.83 - $305.53 $853,254 - $952,031
-3,116 Reduced 1.11%
276,891 $80.2 Million
Q2 2022

Jul 12, 2022

SELL
$234.96 - $292.55 $97.5 Million - $121 Million
-414,752 Reduced 59.7%
280,007 $78.9 Million
Q1 2022

Apr 19, 2022

SELL
$221.42 - $260.97 $39.7 Million - $46.8 Million
-179,213 Reduced 20.51%
694,759 $181 Million
Q4 2021

Jan 27, 2022

BUY
$177.01 - $223.45 $184,798 - $233,281
1,044 Added 0.12%
873,972 $192 Million
Q3 2021

Oct 14, 2021

SELL
$181.39 - $202.99 $4.38 Million - $4.9 Million
-24,153 Reduced 2.69%
872,928 $158 Million
Q2 2021

Jul 19, 2021

BUY
$187.49 - $221.1 $7.29 Million - $8.59 Million
38,865 Added 4.53%
897,081 $181 Million
Q1 2021

Apr 28, 2021

BUY
$207.02 - $241.31 $96.4 Million - $112 Million
465,772 Added 118.68%
858,216 $184 Million
Q4 2020

Jan 20, 2021

BUY
$207.01 - $276.09 $69.5 Million - $92.6 Million
335,562 Added 589.93%
392,444 $92.7 Million
Q3 2020

Oct 29, 2020

BUY
$255.65 - $303.1 $722,722 - $856,863
2,827 Added 5.23%
56,882 $15.5 Million
Q2 2020

Jul 10, 2020

BUY
$225.48 - $295.8 $169,110 - $221,850
750 Added 1.41%
54,055 $15.7 Million
Q1 2020

Apr 13, 2020

SELL
$199.77 - $247.81 $33.1 Million - $41.1 Million
-165,932 Reduced 75.69%
53,305 $12.7 Million
Q4 2019

Jan 10, 2020

SELL
$166.71 - $223.91 $3.08 Million - $4.14 Million
-18,480 Reduced 7.77%
219,237 $48 Million
Q3 2019

Oct 10, 2019

SELL
$166.23 - $187.09 $24.2 Million - $27.2 Million
-145,547 Reduced 37.98%
237,717 $40.3 Million
Q2 2019

Jul 24, 2019

BUY
$164.61 - $190.37 $13.6 Million - $15.7 Million
82,670 Added 27.5%
383,264 $70.3 Million
Q1 2019

Apr 10, 2019

SELL
$163.73 - $194.7 $5.27 Million - $6.27 Million
-32,214 Reduced 9.68%
300,594 $55.3 Million
Q4 2018

Jan 24, 2019

SELL
$151.91 - $192.21 $2.78 Million - $3.52 Million
-18,322 Reduced 5.22%
332,808 $55.1 Million
Q3 2018

Oct 10, 2018

SELL
$167.73 - $192.74 $1.77 Million - $2.04 Million
-10,575 Reduced 2.92%
351,130 $67.7 Million
Q2 2018

Jul 13, 2018

BUY
$145.72 - $169.96 $597,452 - $696,836
4,100 Added 1.15%
361,705 $61.5 Million
Q1 2018

May 01, 2018

SELL
$151.6 - $177.13 $82.6 Million - $96.5 Million
-544,897 Reduced 60.38%
357,605 $58.3 Million
Q4 2017

Feb 05, 2018

BUY
$137.28 - $155.55 $124 Million - $140 Million
902,502
902,502 $135 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Manning & Napier Group, LLC Portfolio

Follow Manning & Napier Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.